Cost-effectiveness of culturing for Chlamydia trachomatis: A study in a clinic for sexually transmitted diseases

M. D. Nettleman, R. B. Jones, S. D. Roberts, Barry Katz, A. E. Washington, R. S. Dittus, T. S. Quinn

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

We have evaluated the cost-effectiveness of using cell culture to test for chlamydial infections in 9979 patients at a clinic for sexually transmitted diseases. From results of cultures, we have established prevalence data and, using decision-theory analysis, have calculated costs and probabilities of various outcomes. According to their histories and presenting signs and symptoms, patients were classified as at high or low risk for chlamydial infections. Empiric treatment of all patients attending the clinic was the most cost-effective strategy, followed by empiric treatment of high-risk women and culture-based treatment of low-risk women. Obtaining cultures for men at high and low risk was not cost-effective. If universal treatment is not provided, the most cost-effective strategy appears to be empiric therapy in patients at high risk for chlamydial infections and therapy based on diagnostic test results in women at low risk.

Original languageEnglish (US)
Pages (from-to)189-196
Number of pages8
JournalAnnals of Internal Medicine
Volume105
Issue number2
StatePublished - 1986
Externally publishedYes

Fingerprint

Chlamydia trachomatis
Sexually Transmitted Diseases
Cost-Benefit Analysis
Costs and Cost Analysis
Therapeutics
Infection
Decision Theory
Decision Support Techniques
Routine Diagnostic Tests
Signs and Symptoms
Cell Culture Techniques

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nettleman, M. D., Jones, R. B., Roberts, S. D., Katz, B., Washington, A. E., Dittus, R. S., & Quinn, T. S. (1986). Cost-effectiveness of culturing for Chlamydia trachomatis: A study in a clinic for sexually transmitted diseases. Annals of Internal Medicine, 105(2), 189-196.

Cost-effectiveness of culturing for Chlamydia trachomatis : A study in a clinic for sexually transmitted diseases. / Nettleman, M. D.; Jones, R. B.; Roberts, S. D.; Katz, Barry; Washington, A. E.; Dittus, R. S.; Quinn, T. S.

In: Annals of Internal Medicine, Vol. 105, No. 2, 1986, p. 189-196.

Research output: Contribution to journalArticle

Nettleman, MD, Jones, RB, Roberts, SD, Katz, B, Washington, AE, Dittus, RS & Quinn, TS 1986, 'Cost-effectiveness of culturing for Chlamydia trachomatis: A study in a clinic for sexually transmitted diseases', Annals of Internal Medicine, vol. 105, no. 2, pp. 189-196.
Nettleman, M. D. ; Jones, R. B. ; Roberts, S. D. ; Katz, Barry ; Washington, A. E. ; Dittus, R. S. ; Quinn, T. S. / Cost-effectiveness of culturing for Chlamydia trachomatis : A study in a clinic for sexually transmitted diseases. In: Annals of Internal Medicine. 1986 ; Vol. 105, No. 2. pp. 189-196.
@article{292a7ebb820b4430a67e4a2e62ed9d81,
title = "Cost-effectiveness of culturing for Chlamydia trachomatis: A study in a clinic for sexually transmitted diseases",
abstract = "We have evaluated the cost-effectiveness of using cell culture to test for chlamydial infections in 9979 patients at a clinic for sexually transmitted diseases. From results of cultures, we have established prevalence data and, using decision-theory analysis, have calculated costs and probabilities of various outcomes. According to their histories and presenting signs and symptoms, patients were classified as at high or low risk for chlamydial infections. Empiric treatment of all patients attending the clinic was the most cost-effective strategy, followed by empiric treatment of high-risk women and culture-based treatment of low-risk women. Obtaining cultures for men at high and low risk was not cost-effective. If universal treatment is not provided, the most cost-effective strategy appears to be empiric therapy in patients at high risk for chlamydial infections and therapy based on diagnostic test results in women at low risk.",
author = "Nettleman, {M. D.} and Jones, {R. B.} and Roberts, {S. D.} and Barry Katz and Washington, {A. E.} and Dittus, {R. S.} and Quinn, {T. S.}",
year = "1986",
language = "English (US)",
volume = "105",
pages = "189--196",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "2",

}

TY - JOUR

T1 - Cost-effectiveness of culturing for Chlamydia trachomatis

T2 - A study in a clinic for sexually transmitted diseases

AU - Nettleman, M. D.

AU - Jones, R. B.

AU - Roberts, S. D.

AU - Katz, Barry

AU - Washington, A. E.

AU - Dittus, R. S.

AU - Quinn, T. S.

PY - 1986

Y1 - 1986

N2 - We have evaluated the cost-effectiveness of using cell culture to test for chlamydial infections in 9979 patients at a clinic for sexually transmitted diseases. From results of cultures, we have established prevalence data and, using decision-theory analysis, have calculated costs and probabilities of various outcomes. According to their histories and presenting signs and symptoms, patients were classified as at high or low risk for chlamydial infections. Empiric treatment of all patients attending the clinic was the most cost-effective strategy, followed by empiric treatment of high-risk women and culture-based treatment of low-risk women. Obtaining cultures for men at high and low risk was not cost-effective. If universal treatment is not provided, the most cost-effective strategy appears to be empiric therapy in patients at high risk for chlamydial infections and therapy based on diagnostic test results in women at low risk.

AB - We have evaluated the cost-effectiveness of using cell culture to test for chlamydial infections in 9979 patients at a clinic for sexually transmitted diseases. From results of cultures, we have established prevalence data and, using decision-theory analysis, have calculated costs and probabilities of various outcomes. According to their histories and presenting signs and symptoms, patients were classified as at high or low risk for chlamydial infections. Empiric treatment of all patients attending the clinic was the most cost-effective strategy, followed by empiric treatment of high-risk women and culture-based treatment of low-risk women. Obtaining cultures for men at high and low risk was not cost-effective. If universal treatment is not provided, the most cost-effective strategy appears to be empiric therapy in patients at high risk for chlamydial infections and therapy based on diagnostic test results in women at low risk.

UR - http://www.scopus.com/inward/record.url?scp=0022491977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022491977&partnerID=8YFLogxK

M3 - Article

C2 - 3089086

AN - SCOPUS:0022491977

VL - 105

SP - 189

EP - 196

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 2

ER -